Vinati Organics (524200) Q4 99/00 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 99/00 earnings summary
28 Oct, 2026Executive summary
FY1999-2000 performance improved significantly, supported by cost controls and better product realizations. Net profit rose to Rs 575.23 lakh from Rs 4.92 lakh.
The business remained centered on Isobutyl Benzene, while development of fine chemicals was planned to diversify the product base.
Financial highlights
Sales and other income were Rs 3,173.88 lakh versus Rs 3,073.42 lakh; gross turnover was Rs 3,141.18 lakh versus Rs 3,024.27 lakh.
Profit before depreciation, non-cash charges and taxes increased 68% to Rs 832.57 lakh from Rs 495.02 lakh; PBT was Rs 693.94 lakh versus Rs 6.98 lakh.
Net profit was Rs 575.23 lakh versus Rs 4.92 lakh; EPS was Rs 8.74.
Interim dividend of 15% was paid and confirmed as the final dividend; dividend and tax absorbed Rs 109.61 lakh.
Outlook and guidance
Fine-chemical projects at Lote MIDC were expected to increase sales and profitability margins and reduce dependence on the existing single product.
CSIR collaborations were underway to develop advanced, eco-friendly and cost-competitive technologies for various products.
Latest events from Vinati Organics
- Higher costs and ATBS destocking cut Q2 profitability; H2 recovery is expected.524200
Q2 26/27 - Higher output and net profit, but lower sales value and no FY98 dividend.524200
Q4 97/98 - Higher raw-material prices cut profit as diversification projects advanced.524200
Q4 00/01 - Sales grew, but a major depreciation catch-up reduced reported net profit to Rs 4.92 lacs.524200
Q4 98/99 - FY05 profit rebounded as IBB improved and ATBS gained market traction.524200
Q4 04/05 - Turnover rose as net profit edged lower and diversification spending advanced.524200
Q4 01/02 - Profit plunged under IBB price pressure as ATBS entered commercial markets.524200
Q4 02/03 - Raw-material inflation cut profit as plant upgrades set up a potential ATBS and SMAS recovery.524200
Q4 03/04 - FY08 sales and PAT surged as export-led growth funded major IBB and ATBS expansions.524200
Q4 07/08